DXCM vs HHS · P/E 63, rev $2.50B vs rev $75.2M
DexCom Inc (DXCM) versus Harte Hanks Inc (HHS) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Harte Hanks Inc (HHS) is a conglomerates company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported HHS revenue for 2026-06-30 was $75.2M. Net income was -$5.6M. HHS currently screens at market cap $27.7M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. HHS currently screens at market cap $27.7M.
Not investment advice. Open the DXCM and HHS stock pages for the full models.
Not investment advice.